Democratic Republic of the Congo vs Marshall Islands: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Democratic Republic of the Congo
63.0%
in 2025
Marshall Islands
62.0%
in 2025
Democratic Republic of the Congo rank
140th
Marshall Islands rank
142nd
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Democratic Republic of the Congo
- Marshall Islands
How they compare
Democratic Republic of the Congo currently reports 63.0% against 62.0% in Marshall Islands, a difference of 1.0%.
The two have swapped places 7 times across 18 shared years of data; in 2008 it was Marshall Islands ahead.
Democratic Republic of the Congo ranks 140th and Marshall Islands ranks 142nd of 192 countries.
Across the 3 decades both report, Democratic Republic of the Congo averaged higher in 1 and Marshall Islands in 2.
Head to head by decade
| Decade | Democratic Republic of the Congo | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 24.5% | 24.5% | Marshall Islands |
| 2010s | 44.9% | 51.4% | 6.5% | Marshall Islands |
| 2020s | 63.5% | 52.3% | 11.2% | Democratic Republic of the Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Democratic Republic of the Congo or Marshall Islands?
- Democratic Republic of the Congo, at 63.0% against 62.0% in Marshall Islands as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Democratic Republic of the Congo and Marshall Islands?
- 1.0%, with Democratic Republic of the Congo ahead.
- How many years of comparable data are there for Democratic Republic of the Congo and Marshall Islands?
- 18 years are reported by both, from 2008 to 2025.
- How do Democratic Republic of the Congo and Marshall Islands rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Democratic Republic of the Congo ranks 140th and Marshall Islands ranks 142nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.